Integrative Research Associates

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Coronary artery disease2 trials
• Heart failure1 trial

Phase

• Phase 32 trials

Status

• Completed2 trials

Lead sponsor

• Boehringer Ingelheim1 trial
• Janssen Research & Development, LLC1 trial

Closed trials

• Completed

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

  NCT04509674· Phase 3· Boehringer Ingelheim· Source